Exaprin Plus Tablet, Film Coated
FDA Label NDC 50332-0144

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Hart Health for the product Exaprin Plus (NDC 50332-0144). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients (in each caplet), purpose, uses, warning, do not use, ask a doctor before use if, ask a doctor or pharmacist before use if you, stop use and ask a doctor if, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Overdosage

Overdose warning

taking more than the recommended dose (overdose) may cause liver damage. Quick medical attention is critical for adult as well as for children even if you do not notice any signs or symptoms. In case of overdose, get medical help or contact a Poison Control Center right away. 1-800-222-1222

* Please review the disclaimer below.